To note that one patient with MSI-H/high TMB endometrioid endometrial carcinoma progressed on immunotherapy very fast but showed a partial response to PI3K inhibitor lasting for 7 months. The gene discussed is PIK3CA; the disease is endometrial endometrioid carcinoma.